ARCT: Arcturus Therapeutics Holdings Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 483.51
Enterprise Value ($M) 246.33
Book Value ($M) 261.87
Book Value / Share 9.67
Price / Book 1.85
NCAV ($M) 222.03
NCAV / Share 8.20
Price / NCAV 2.18

Profitability (mra)
Return on Invested Capital (ROIC) -0.22
Return on Assets (ROA) -0.14
Return on Equity (ROE) -0.22

Liquidity (mrq)
Quick Ratio 4.76
Current Ratio 4.76

Balance Sheet (mrq) ($M)
Current Assets 330.82
Assets 370.65
Liabilities 108.79
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
11-08 13G Nikko Asset Management Americas, Inc. 8.56 75.31
11-05 13G Sumitomo Mitsui Trust Holdings, Inc. 8.56 75.31
04-05 13G/A BlackRock, Inc. 10.20 14.37
02-13 13G/A Vanguard Group Inc 5.46 0.55
01-29 13G/A ARK Investment Management LLC 7.66 1.75
01-25 13G/A State Street Corp 6.10 -2.29
01-17 13G/A Federated Hermes, Inc. 17.63 11.13

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-11-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-08-05 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-05-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-03-14 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-12-06 149,036 445,053 33.49
2024-12-05 107,141 329,852 32.48
2024-12-04 72,939 293,082 24.89
2024-12-03 126,394 360,884 35.02
2024-12-02 81,936 244,989 33.44

(click for more detail)

Similar Companies
APGE – Apogee Therapeutics, Inc. APLT – Applied Therapeutics, Inc.
AQST – Aquestive Therapeutics, Inc. ARDX – Ardelyx, Inc.
ATAI – Atai Life Sciences N.V.


Financial data and stock pages provided by
Fintel.io